Skip to main navigation Skip to search Skip to main content

Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology